An observational study in Obesity and Sarcopenic Obesity, sponsored by Istituto Auxologico Italiano. Recruiting at 1 site in Italy. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Istituto Auxologico Italiano · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Obesity by Istituto Auxologico Italiano — 11 open to participants now, 12 under way, none of them phase 3. Obesity · Istituto Auxologico Italiano.
Among the 42 studies in Obesity by Istituto Auxologico Italiano, this one is the 6th largest by planned enrollment of the 20 observational ones that give a count, is the only one that started in 2025, is one of 20 observational ones, reaches primary completion later than 7 of the 11 other live ones, and was the 41st registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →11 of the 42 studies in Obesity by Istituto Auxologico Italiano are open now, in 1 country. Recruiting first, the newest first:
Istituto Auxologico Italiano · Sites in Italy
Ages 30–70 · Healthy volunteers
Istituto Auxologico Italiano · Sites in Italy
Ages 18–55 · Women only · Healthy volunteers
Istituto Auxologico Italiano · Sites in Italy
Ages 18–60
Istituto Auxologico Italiano · Sites in Italy
Ages 18–65 · Women only
Istituto Auxologico Italiano · Sites in Italy
Ages 18–75
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 160 is above the median of 115 across 2,159 observational studies indexed under Obesity.
Median enrollment 32 across the 22 interventional studies, 80 across the 20 observational. Of the 30 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istituto Auxologico Italiano is the lead sponsor of 204 studies on the registry; 70 are open to participants now.
5 of the studies in Obesity by Istituto Auxologico Italiano that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05759637Istituto Auxologico ItalianoType 2 Diabetes, Obesity and Cortisol Excess | 2026-12-31 |
| NCT07614464Istituto Auxologico ItalianoEffects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults | 2026-12-31 |
| NCT05781269Istituto Auxologico ItalianoLong Term Effect of Very-low-calories Ketogenic Diet on Weight Control and Cardiovascular Brisk Factors (KETOHEART) | 2026-12-31 |
| NCT05772052Istituto Auxologico ItalianoAbnormal Eating and Taste Perception in Subjects With Obesity | 2026-12-31 |
| NCT07935473Istituto Auxologico ItalianoEffects of "Exercise Snack" in Individuals With Obesity | 2027-02-25 |
Add all 5 to your calendar (.ics) → With an account.
Among the 42 studies in Obesity by Istituto Auxologico Italiano, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Obesity is a significant health problem whose prevalence has tripled worldwide in the last fifty years, also involving older people. Older people present sarcopenia, characterized by the progressive loss of muscle mass and strength. Sarcopenia, accompanied by an increase in adipose tissue, causes a specific condition called sarcopenic obesity. The increase in adipose tissue and the decrease in muscle mass determines a reduction in strength and physical abilities necessary to perform everyday activities of daily living in obese older people.
To understand how the condition of excess adipose tissue influences the activities of daily living of older people with obesity, it is necessary to compare the physical abilities, body composition, and results of various motor skills with normal-weight subjects, corrected for sex and age.
Hospitalized obese elderly following a 3-week integrated metabolic rehabilitation program
+ Normal weight elderly attending correct lifestyle program in their home town
Obese elderly:
Inclusion Criteria:
Exclusion Criteria:
Normal weight elderly:
Inclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Obese men and women of 65 years and older
Other: Fitness tests and questionnaires
Normal weight men and women of 65 years and older
Other: Fitness tests and questionnaires
Anthropometric measurements, physical fitness tests and daily life questionnaires
Fat mass
Fat mass as assessed by bioelectrical impedance
Time frame: Baseline
Lean mass
Lean mass as assessed by bioelectrical impedance
Time frame: Baseline
Barthel Index
Level of independence in 10 basic daily activities (ADLs) Total score ranges from 0 to 100
Time frame: Baseline
Handgrip test
Score in kilograms (kg) using a hand dynamometer
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Started May 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.
Of 796 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's planned 19 months is below that.
Counting every sponsor, half of 842 studies reached it within 39 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituto Auxologico Italiano →